Eli Lilly & Co (1LLY) Stock Statistics & Valuation Metrics
Total Valuation
Eli Lilly & Co has a market cap or net worth of EUR 1.18T. The enterprise value is EUR 1.08T.
- Market Cap
- EUR 1.18T
- Enterprise Value
- EUR 1.08T
Share Statistics
Eli Lilly & Co has 940,745,060 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 940,745,060
- Owned by Insiders
- 9.92%
- Owned by Institutions
- 54.51%
Financial Efficiency
Eli Lilly & Co’s return on equity (ROE) is 0.78 and return on invested capital (ROIC) is 30.20%.
- Return on Equity (ROE)
- 0.78
- Return on Assets (ROA)
- 0.18
- Return on Invested Capital (ROIC)
- 30.20%
- Return on Capital Employed (ROCE)
- 0.38
- Revenue Per Employee
- 1.30M
- Profits Per Employee
- 412.80K
- Employee Count
- 50,000
- Asset Turnover
- 0.58
- Inventory Turnover
- 0.80
Valuation Ratios
The current PE Ratio of Eli Lilly & Co is 45.90. Eli Lilly & Co’s PEG ratio is 0.91.
- PE Ratio
- 45.90
- PS Ratio
- 15.43
- PB Ratio
- 31.40
- Price to FCF
- 67.84
- Price to Operating Cash Flow
- 41.26
- PEG Ratio
- 0.91
Income Statement
In the last 12 months, Eli Lilly & Co had revenue of 65.18B and earned 20.64B in profits. Earnings per share was 23.07.
- Revenue
- 65.18B
- Gross Profit
- 54.13B
- Operating Income
- 29.70B
- Pretax Income
- 25.73B
- Net Income
- 20.64B
- EBITDA
- 31.69B
- Earnings Per Share (EPS)
- 23.07
Cash Flow
In the last 12 months, operating cash flow was 30.64B and capital expenditures -10.98B, giving a free cash flow of 19.66B billion.
- Operating Cash Flow
- 30.64B
- Free Cash Flow
- 19.66B
- Free Cash Flow per Share
- 22.04
Dividends & Yields
Eli Lilly & Co pays an annual dividend of ―, resulting in a dividend yield of 0.45%
- Dividend Per Share
- ―
- Dividend Yield
- 0.45%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 1.47%
- Earnings Yield
- 2.18%
Stock Price Statistics
- Beta
- 0.45
- 52-Week Price Change
- 61.76%
- 50-Day Moving Average
- 1057.05
- 200-Day Moving Average
- 948.02
- Relative Strength Index (RSI)
- 71.86
- Average Volume (3m)
- 425
Important Dates
Eli Lilly & Co upcoming earnings date is Feb 10, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Oct 29, 2026
- Next Earnings Date
- Feb 10, 2027
- Ex-Dividend Date
- ―
Financial Position
Eli Lilly & Co as a current ratio of 1.58, with Debt / Equity ratio of 160.18%
- Current Ratio
- 1.58
- Quick Ratio
- 1.19
- Debt to Market Cap
- 0.04
- Net Debt to EBITDA
- 1.12
- Interest Coverage Ratio
- 37.34
Taxes
In the past 12 months, Eli Lilly & Co has paid 5.09B in taxes.
- Income Tax
- 5.09B
- Effective Tax Rate
- 0.20
Enterprise Valuation
Eli Lilly & Co EV to EBITDA ratio is 30.85, with an EV/FCF ratio of 70.22.
- EV to Sales
- 15.97
- EV to EBITDA
- 30.85
- EV to Free Cash Flow
- 70.22
- EV to Operating Cash Flow
- 45.05
Balance Sheet
Eli Lilly & Co has EUR 4.88B in cash and marketable securities with EUR 49.50B in debt, giving a net cash position of -EUR 44.62B billion.
- Cash & Marketable Securities
- EUR 4.88B
- Total Debt
- EUR 49.50B
- Net Cash
- -EUR 44.62B
- Net Cash Per Share
- -EUR 47.43
- Tangible Book Value Per Share
- EUR 13.81
Margins
Gross margin is 83.63%, with operating margin of 46.07%, and net profit margin of 31.90%.
- Gross Margin
- 83.63%
- Operating Margin
- 46.07%
- Pretax Margin
- 40.21%
- Net Profit Margin
- 31.90%
- EBITDA Margin
- 51.76%
- EBIT Margin
- 49.24%
Analyst Forecast
The average price target for Eli Lilly & Co is EUR 1,348.94, which is 11.43% higher than the current price. The consensus rating is Strong Buy
- Price Target
- EUR 1,348.94
- Price Target Upside
- 5.93% Upside
- Analyst Consensus
- Strong Buy
- Analyst Count
- 24
- Revenue Growth Forecast
- 39.01%
- EPS Growth Forecast
- 44.35%
Scores
- Smart Score
- 10
- AI Score
- ―
